Return on Assets (ROA): 6.71%
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 6.71% is 69% below its 5-year average of 21.45%, near the low end of its 5-year range (6.71%–27.93%).
As of Sunday, June 28, 2026. 50.84% below its 12-month average of 13.65%.
NRC Return on Assets (ROA) Chart
Annual fiscal-year return on assets; no daily interpolation.
NRC Average Return on Assets (ROA) Chart
NRC Current vs Average Return on Assets (ROA) Chart
NRC Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
6.71%
RETURN ON ASSETS (ROA) AVG TTM
13.65%
RETURN ON ASSETS (ROA) AVG 3Y
19.24%
RETURN ON ASSETS (ROA) AVG 5Y
21.45%
RETURN ON ASSETS (ROA) AVG 10Y
21.32%
RETURN ON ASSETS (ROA) AVG 15Y
18.62%
RETURN ON ASSETS (ROA) AVG 20Y
16.79%
CURRENT VS TTM AVG
-50.84%
CURRENT VS 3Y AVG
-65.13%
CURRENT VS 5Y AVG
-68.72%
CURRENT VS 10Y AVG
-68.53%
CURRENT VS 15Y AVG
-63.97%
CURRENT VS 20Y AVG
-60.03%
NRC Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 6.71% | 13.65% | 19.24% | 21.45% |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | -27.49% | -30.00% | -27.77% | -27.77% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -163.04% | -172.19% | -99.08% | -83.15% |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | -6.10% | -17.46% | -82.63% | -55.94% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | -12.01% | -13.41% | -10.26% | -6.23% |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 11.98% | 11.11% | 1.40% | -7.68% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.57B | -0.58% | 11.88% | 0.12% | -6.73% |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | -0.42% | -3.24% | -6.85% | -10.42% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 1.72% | -6.26% | -11.14% | 1.46% |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 9.70% | 8.61% | 6.84% | 6.99% |
Asset Efficiency
ROA
6.7%
ROE
66.9%
Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for National Research Corporation (NRC)?
- The return on assets (ROA) for NRC stock is 6.71%.
- Is National Research Corporation's return on assets (ROA) high or low?
- The return on assets (ROA) of 6.71% is 69% below its 5-year average of 21.45%, near the low end of its 5-year range (6.71%–27.93%).
- What is the TTM average return on assets (ROA) for National Research Corporation (NRC)?
- The TTM average return on assets (ROA) for NRC stock is 13.65%.
- What is the 3Y average return on assets (ROA) for National Research Corporation (NRC)?
- The 3Y average return on assets (ROA) for NRC stock is 19.24%.
- What is the 5Y average return on assets (ROA) for National Research Corporation (NRC)?
- The 5Y average return on assets (ROA) for NRC stock is 21.45%.
- What is the 10Y average return on assets (ROA) for National Research Corporation (NRC)?
- The 10Y average return on assets (ROA) for NRC stock is 21.32%.
- What is the 15Y average return on assets (ROA) for National Research Corporation (NRC)?
- The 15Y average return on assets (ROA) for NRC stock is 18.62%.
- What is the 20Y average return on assets (ROA) for National Research Corporation (NRC)?
- The 20Y average return on assets (ROA) for NRC stock is 16.79%.
NRC Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 8.60% |
| 2024-12-31 | 18.70% |
| 2023-12-31 | 25.30% |
| 2022-12-31 | 24.38% |
| 2021-12-31 | 23.78% |
| 2020-12-31 | 27.93% |
| 2019-12-31 | 29.28% |
| 2018-12-31 | 27.90% |
| 2017-12-31 | 18.02% |
| 2016-12-31 | 17.01% |
| 2015-12-31 | 13.64% |
| 2014-12-31 | 14.02% |
| 2013-12-31 | 13.95% |
| 2012-12-31 | 15.06% |
| 2011-12-31 | 11.49% |
| 2010-12-31 | 8.89% |
| 2009-12-31 | 11.71% |
| 2008-12-31 | 10.54% |
| 2007-12-31 | 11.05% |
| 2006-12-31 | 9.56% |
| 2005-12-31 | 11.72% |
| 2004-12-31 | 9.49% |
| 2003-12-31 | 9.60% |
| 2002-12-31 | 9.91% |
| 2001-12-31 | 4.95% |
| 2000-12-31 | 8.59% |
| 1999-12-31 | 5.12% |
| 1998-12-31 | 1.90% |
| 1997-12-31 | 14.16% |
| 1996-12-31 | 37.10% |
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green